Very excited to share that since launch 2.5 y ago, users of https://t.co/AV313B9wQe have cumulatively answered 405,724 questions. That's a heck of a lot of studying folks!
@pathqbank
Keep up the great work!
This morning, @PipNicolson and I spent nearly 2 hours recording a discussion of this paper on Exa-cel therapy for severe sickle cell disease. Our podcast is called "Don't Just Read the Abstract" and this paper exemplifies how important that is!
A 🧵
After last week’s round-up of recent non-malignant studies went down quite well, I’ll do this every few weeks from now on. So, here’s 7 papers from the last 7 days.
For more from me, follow my pod discussing non-malig haem trials - Don't Just Read the Abstract with @PipNicolson
Do you see patients with secondary polycythaemia. Are you frustrated by the lack of evidence to guide practice? Do you offer / not offer venesection?
Please help us work up to an RCT of venesection vs none by filling out our survey:
https://t.co/8i4QT8PFU2
This course on haemostasis and thrombosis (aimed at FRCPath Part 2) from our friends @blood_academy looks great with fantastic faculty - not many that are better to learn from.
https://t.co/NW35Y3szIi
@HaemSTAR webinar tomorrow 10-5-24 at 08:30 BST with @Richard_D_Riley. How to get your article rejected by the BMJ: 12 common statistical issues. It'll be a good one and plenty of opportunity for questions. Don't miss it!
https://t.co/7QQuAjZdpO
Massive good luck to those doing FRCPath Part 1. For those who have used our site, we hope that it's helped you! For essays, focus on what you do know rather than on what you don't. If you've been a dilligent haematology registrar, you will know a lot! Best wishes!
New question at https://t.co/0SFAkefeTO based on new guidance from @isth on management of cancer associated thrombosis in patients who are thrombocytopenic. Suggestions for improvement or other questions welcome.
https://t.co/snNSRxFiEK
Need a last minute boost to your FRCPath Haematology revision. Sign up for our 1 month subscription and start learning today. >900 MCQs/EMQs across malignant, general haem, transfusion and H&T.
Looking for an interesting webinar with CPD credits from @RCPath? The first of @HaemSTAR_UK and @thelimbichaemUK's breakfast webinars is Ian Roberts who played a lead part in the WOMAN trials of TXA.
SIGN UP: https://t.co/15pXm4I7ID
Join us & @HaemSTAR_UK as Prof. Ian Roberts discusses the key results and implications of the WOMAN-2 trial that found a link between maternal anaemia, PPH & the risk of death.
Host: @richardbuka
We are hugely excited to be launching our research-themed webinar series in collaboration with @thelimbichaemUK.
Friday mornings 08:30 - 09:15 BST.
#1 is Friday 15th September with Prof Ian Roberts, who played lead rolls in the CRASH and WOMAN trials
https://t.co/MO0ZAL4imc
Have written a new blog post on intervention bias in classical / non-malignant haematology. Explores how we are susceptible to over-treating our patients and how this can lead to harm.
https://t.co/trVghxmsKU